Long non-coding RNA MIR22HG suppresses cell proliferation and promotes apoptosis in prostate cancer cells by sponging microRNA-9-3p

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Du Z, Sun T, Hacisuleyman E, et al. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun. 2016;7:10982.
   PubMed Web of Science ®Google Scholar
• Wilt TJ, Jones KM, Barry MJ, et al. Follow-up of prostatectomy versus observation for early prostate cancer. N Engl J Med. 2017;377(2):132–142.
   PubMed Web of Science ®Google Scholar
• Loeb S, Folkvaljon Y, Makarov DV, et al. Five-year nationwide follow-up study of active surveillance for prostate cancer. Eur Urol. 2015;67(2):233–238.
   PubMed Web of Science ®Google Scholar
• Klotz L, Vesprini D, Sethukavalan P, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol. 2015;33:272–277.
   PubMed Web of Science ®Google Scholar
• Petrylak DP. Current state of castration-resistant prostate cancer. Am J Manag Care. 2013;19:s358–65.
   PubMed Web of Science ®Google Scholar
• Wang Q, Li W, Liu XS, et al. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell. 2007;27(3):380–392.
   PubMed Web of Science ®Google Scholar
• Tran C, Ouk S, Clegg NJ, et al. Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science. 2009;324(5928):787–790.
   PubMed Web of Science ®Google Scholar
• Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev. 2010;24(18):1967–2000.
   PubMed Web of Science ®Google Scholar
• Spizzo R, Almeida MI, Colombatti A, et al. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012;31(43):4577–4587.
   PubMed Web of Science ®Google Scholar
• Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703–719.
   PubMed Web of Science ®Google Scholar
• Su W, Guo C, Wang L, et al. LncRNA MIR22HG abrogation inhibits proliferation and induces apoptosis in esophageal adenocarcinoma cells via activation of the STAT3/c-Myc/FAK signaling. Aging (Albany NY). 2019;11(13):4587–4596.
   PubMedGoogle Scholar
• Dong Y, Yan W, Zhang SL, et al. Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy. Oncotarget. 2017;8:114041–114049.
   PubMedGoogle Scholar
• Wu Y, Zhou Y, Huan L, et al. LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells. Cancer Sci. 2019;110:973–984.
   PubMed Web of Science ®Google Scholar
• Shen H, Weng XD, Yang D, et al. Long noncoding RNA MIR22HG is down-regulated in prostate cancer. Math Biosci Eng. 2019;17:1776–1786.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Long H, Li Q, Xiao Z, et al. LncRNA MIR22HG promotes osteoarthritis progression via regulating miR-9-3p/ADAMTS5 pathway. Bioengineered. 2021;12:3148–3158.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Y, Wang S, et al. SP1-induced lncRNA ZFPM2 antisense RNA 1 (ZFPM2-AS1) aggravates glioma progression via the miR-515-5p/Superoxide dismutase 2 (SOD2) axis. Bioengineered. 2021;12:2299–2310.
   PubMed Web of Science ®Google Scholar
• Gong H. Pinocembrin suppresses proliferation and enhances apoptosis in lung cancer cells in vitro by restraining autophagy. Bioengineered. 2021;12:6035–6044.
   PubMed Web of Science ®Google Scholar
• Mitobe Y, Takayama KI, Horie-Inoue K, et al. Prostate cancer-associated lncRNAs. Cancer Lett. 2018;418:159–166.
   PubMed Web of Science ®Google Scholar
• Hua JT, Chen S, He HH. Landscape of Noncoding RNA in Prostate Cancer. Trends Genet. 2019;35:840–851.
   PubMed Web of Science ®Google Scholar
• Guo H, Ahmed M, Zhang F, et al. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer. Nat Genet. 2016;48:1142–1150.
   PubMed Web of Science ®Google Scholar
• Lingadahalli S, Jadhao S, Sung YY, et al. Novel lncRNA LINC00844 Regulates Prostate Cancer Cell Migration and Invasion through AR Signaling. Mol Cancer Res. 2018;16:1865–1878.
   PubMed Web of Science ®Google Scholar
• Han M, Wang S, Fritah S, et al. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/beta-catenin signalling. Brain. 2020;143:512–530.
   PubMed Web of Science ®Google Scholar
• Cui Z, An X, Li J, et al. LncRNA MIR22HG negatively regulates miR-141-3p to enhance DAPK1 expression and inhibits endometrial carcinoma cells proliferation. Biomed Pharmacother. 2018;104:223–228.
   PubMed Web of Science ®Google Scholar
• Xu J, Shao T, Song M, et al. MIR22HG acts as a tumor suppressor via TGFbeta/SMAD signaling and facilitates immunotherapy in colorectal cancer. Mol Cancer. 2020;19:51.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Chen H, Ali M, Ruben A, et al. E2F6-mediated downregulation of MIR22HG facilitates the progression of laryngocarcinoma by targeting the miR-5000-3p/FBXW7 axis. Mol Cell Biol. 2020;40(10):e00496–19.
   PubMed Web of Science ®Google Scholar
• Zhong X, Huang G, Ma Q, et al. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis. Medicine (Baltimore). 2019;98(27):e16269.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang S, Zhao R, et al. Upregulated miR-9-3p promotes cell growth and inhibits apoptosis in medullary thyroid carcinoma by targeting BLCAP. Oncol Res. 2017;25(8):1215–1222.
   PubMed Web of Science ®Google Scholar
• Tinay I, Tan M, Gui B, et al. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer. Prostate. 2018;78(12):927–937.
   PubMed Web of Science ®Google Scholar